HDCN Article Review/Hyperlink

Assent-3 Investigators

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction

Lancet (Aug) 358:605-613, 2001

The full text of this paper is available from the Lancet. However, you must register at the Lancet site first as a non-subscriber (you can get there via the journals page of HDCN).

Once you have registered at the Lancet site, click on this link.
         Related Folders:

Return to Home
Page